PDB Short entry for 2FL2 HEADER CELL CYCLE 05-JAN-06 2FL2 TITLE CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 19 COMPND MOL_ID: 1; COMPND 2 MOLECULE: KINESIN-LIKE PROTEIN KIF11; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINESIN-MOTOR DOMAIN, RESIDUES 1-368; COMPND 5 SYNONYM: KINESIN-RELATED MOTOR PROTEIN EG5, KINESIN-LIKE SPINDLE COMPND 6 PROTEIN HKSP, THYROID RECEPTOR INTERACTING PROTEIN 5, TRIP5, KINESIN- COMPND 7 LIKE PROTEIN 1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIF11, EG5, KNSL1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSETA KEYWDS KSP, KSP-INHIBITOR COMPLEX, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR Y.YAN REVDAT 4 14-FEB-24 2FL2 1 REMARK LINK REVDAT 3 24-FEB-09 2FL2 1 VERSN REVDAT 2 27-JUN-06 2FL2 1 JRNL REVDAT 1 07-FEB-06 2FL2 0 JRNL AUTH M.E.FRALEY,R.M.GARBACCIO,K.L.ARRINGTON,W.F.HOFFMAN, JRNL AUTH 2 E.S.TASBER,P.J.COLEMAN,C.A.BUSER,E.S.WALSH,K.HAMILTON, JRNL AUTH 3 C.FERNANDES,M.D.SCHABER,R.B.LOBELL,W.TAO,V.J.SOUTH,Y.YAN, JRNL AUTH 4 L.C.KUO,T.PRUEKSARITANONT,C.SHU,M.TORRENT,D.C.HEIMBROOK, JRNL AUTH 5 N.E.KOHL,H.E.HUBER,G.D.HARTMAN JRNL TITL KINESIN SPINDLE PROTEIN (KSP) INHIBITORS. PART 2: THE JRNL TITL 2 DESIGN, SYNTHESIS, AND CHARACTERIZATION OF JRNL TITL 3 2,4-DIARYL-2,5-DIHYDROPYRROLE INHIBITORS OF THE MITOTIC JRNL TITL 4 KINESIN KSP. JRNL REF BIOORG.MED.CHEM.LETT. V. 16 1775 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16439123 JRNL DOI 10.1016/J.BMCL.2006.01.030 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 53.0 REMARK 3 NUMBER OF REFLECTIONS : 14627 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.257 REMARK 3 FREE R VALUE : 0.316 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1613 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5188 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 129 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 BOND ANGLES (DEGREES) : 2.110 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FL2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000036005. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18467 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 53.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : 0.11000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 32.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.33600 REMARK 200 R SYM FOR SHELL (I) : 0.33600 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, POTASSIUM PHOSPHATE, PH 8, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.40000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.50000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.75000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.50000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.40000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.75000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS MOTOR DOMAIN IS A PART OF MULTI-DOMAIN PROTIEN THAT REMARK 300 FORMS A TETRAMER, THERE ARE TWO MONOMERS IN AN ASYMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 GLN A 4 REMARK 465 PRO A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 LYS A 10 REMARK 465 LYS A 11 REMARK 465 LYS A 12 REMARK 465 GLU A 13 REMARK 465 GLU A 14 REMARK 465 LYS A 15 REMARK 465 GLY A 16 REMARK 465 LYS A 17 REMARK 465 ILE A 272 REMARK 465 GLY A 273 REMARK 465 ARG A 274 REMARK 465 SER A 275 REMARK 465 GLY A 276 REMARK 465 ALA A 277 REMARK 465 VAL A 278 REMARK 465 ASP A 279 REMARK 465 LYS A 280 REMARK 465 ARG A 281 REMARK 465 ALA A 282 REMARK 465 ARG A 283 REMARK 465 GLU A 284 REMARK 465 ALA A 285 REMARK 465 GLY A 286 REMARK 465 PRO A 363 REMARK 465 GLU A 364 REMARK 465 VAL A 365 REMARK 465 ASN A 366 REMARK 465 GLN A 367 REMARK 465 LYS A 368 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 GLN B 4 REMARK 465 PRO B 5 REMARK 465 ASN B 6 REMARK 465 SER B 7 REMARK 465 SER B 8 REMARK 465 ALA B 9 REMARK 465 LYS B 10 REMARK 465 LYS B 11 REMARK 465 LYS B 12 REMARK 465 GLU B 13 REMARK 465 GLU B 14 REMARK 465 LYS B 15 REMARK 465 GLY B 16 REMARK 465 LYS B 17 REMARK 465 ILE B 272 REMARK 465 GLY B 273 REMARK 465 ARG B 274 REMARK 465 SER B 275 REMARK 465 GLY B 276 REMARK 465 ALA B 277 REMARK 465 VAL B 278 REMARK 465 ASP B 279 REMARK 465 LYS B 280 REMARK 465 ARG B 281 REMARK 465 ALA B 282 REMARK 465 ARG B 283 REMARK 465 GLU B 284 REMARK 465 ALA B 285 REMARK 465 GLY B 286 REMARK 465 PRO B 363 REMARK 465 GLU B 364 REMARK 465 VAL B 365 REMARK 465 ASN B 366 REMARK 465 GLN B 367 REMARK 465 LYS B 368 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 124 O HOH B 607 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 36 79.00 42.66 REMARK 500 LEU A 57 128.85 104.59 REMARK 500 ARG A 189 -96.41 -76.72 REMARK 500 ASP A 208 20.04 -74.19 REMARK 500 GLU A 313 5.00 -69.56 REMARK 500 LEU B 57 -161.98 -123.03 REMARK 500 LYS B 60 121.20 -170.96 REMARK 500 ALA B 74 -6.51 -59.00 REMARK 500 ASP B 149 43.86 -149.47 REMARK 500 THR B 249 -178.45 -68.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 603 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 112 OG1 REMARK 620 2 ADP A 601 O3B 59.5 REMARK 620 3 HOH A 638 O 80.2 102.4 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 602 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR B 112 OG1 REMARK 620 2 ADP B 600 O3B 77.2 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE N4T A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE N4T B 605 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FKY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 13 REMARK 900 RELATED ID: 2FL6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 6 REMARK 999 REMARK 999 SEQUENCE REMARK 999 MET AT POSITION 1 WAS CLEAVED DURING PURIFICATION DBREF 2FL2 A 2 368 UNP P52732 KIF11_HUMAN 2 368 DBREF 2FL2 B 2 368 UNP P52732 KIF11_HUMAN 2 368 SEQRES 1 A 367 ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU GLU SEQRES 2 A 367 LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG PRO SEQRES 3 A 367 PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER ILE SEQRES 4 A 367 VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL ARG SEQRES 5 A 367 THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR TYR SEQRES 6 A 367 THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN ILE SEQRES 7 A 367 ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP GLU SEQRES 8 A 367 VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR GLY SEQRES 9 A 367 GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY GLU SEQRES 10 A 367 ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP PRO SEQRES 11 A 367 LEU ALA GLY ILE ILE PRO ARG THR LEU HIS GLN ILE PHE SEQRES 12 A 367 GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL LYS SEQRES 13 A 367 VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE ASP SEQRES 14 A 367 LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU GLN SEQRES 15 A 367 MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE ILE SEQRES 16 A 367 LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP GLU SEQRES 17 A 367 VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG THR SEQRES 18 A 367 THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SER SEQRES 19 A 367 HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU THR SEQRES 20 A 367 THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS LEU SEQRES 21 A 367 ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY ARG SEQRES 22 A 367 SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY ASN SEQRES 23 A 367 ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE THR SEQRES 24 A 367 ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG GLU SEQRES 25 A 367 SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY GLY SEQRES 26 A 367 ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO ALA SEQRES 27 A 367 SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU TYR SEQRES 28 A 367 ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU VAL SEQRES 29 A 367 ASN GLN LYS SEQRES 1 B 367 ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU GLU SEQRES 2 B 367 LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG PRO SEQRES 3 B 367 PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER ILE SEQRES 4 B 367 VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL ARG SEQRES 5 B 367 THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR TYR SEQRES 6 B 367 THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN ILE SEQRES 7 B 367 ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP GLU SEQRES 8 B 367 VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR GLY SEQRES 9 B 367 GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY GLU SEQRES 10 B 367 ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP PRO SEQRES 11 B 367 LEU ALA GLY ILE ILE PRO ARG THR LEU HIS GLN ILE PHE SEQRES 12 B 367 GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL LYS SEQRES 13 B 367 VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE ASP SEQRES 14 B 367 LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU GLN SEQRES 15 B 367 MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE ILE SEQRES 16 B 367 LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP GLU SEQRES 17 B 367 VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG THR SEQRES 18 B 367 THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SER SEQRES 19 B 367 HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU THR SEQRES 20 B 367 THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS LEU SEQRES 21 B 367 ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY ARG SEQRES 22 B 367 SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY ASN SEQRES 23 B 367 ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE THR SEQRES 24 B 367 ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG GLU SEQRES 25 B 367 SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY GLY SEQRES 26 B 367 ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO ALA SEQRES 27 B 367 SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU TYR SEQRES 28 B 367 ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU VAL SEQRES 29 B 367 ASN GLN LYS HET MG A 603 1 HET ADP A 601 27 HET N4T A 604 26 HET MG B 602 1 HET ADP B 600 27 HET N4T B 605 26 HETNAM MG MAGNESIUM ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM N4T (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2- HETNAM 2 N4T PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE FORMUL 3 MG 2(MG 2+) FORMUL 4 ADP 2(C10 H15 N5 O10 P2) FORMUL 5 N4T 2(C21 H20 F2 N2 O) FORMUL 9 HOH *129(H2 O) HELIX 1 1 ASN A 29 ALA A 35 1 7 HELIX 2 2 PRO A 45 ARG A 47 5 3 HELIX 3 3 LYS A 77 VAL A 85 1 9 HELIX 4 4 VAL A 85 MET A 95 1 11 HELIX 5 5 GLY A 110 GLU A 116 1 7 HELIX 6 6 SER A 120 GLU A 124 5 5 HELIX 7 7 GLY A 134 ASN A 150 1 17 HELIX 8 8 ASN A 206 ASP A 208 5 3 HELIX 9 9 GLU A 209 MET A 228 1 20 HELIX 10 10 ALA A 230 SER A 235 1 6 HELIX 11 11 ASN A 289 GLU A 304 1 16 HELIX 12 12 PRO A 310 GLU A 313 5 4 HELIX 13 13 SER A 314 LEU A 320 1 7 HELIX 14 14 GLN A 321 LEU A 324 5 4 HELIX 15 15 ALA A 339 LEU A 341 5 3 HELIX 16 16 ASN A 342 LYS A 357 1 16 HELIX 17 17 ASN B 29 ALA B 35 1 7 HELIX 18 18 LYS B 77 VAL B 85 1 9 HELIX 19 19 VAL B 85 MET B 95 1 11 HELIX 20 20 GLY B 110 GLU B 116 1 7 HELIX 21 21 SER B 120 GLU B 124 5 5 HELIX 22 22 THR B 126 ASP B 130 5 5 HELIX 23 23 GLY B 134 LEU B 147 1 14 HELIX 24 24 GLU B 209 MET B 228 1 20 HELIX 25 25 ALA B 230 SER B 235 1 6 HELIX 26 26 ASN B 289 GLU B 304 1 16 HELIX 27 27 PRO B 310 GLU B 313 5 4 HELIX 28 28 SER B 314 LEU B 320 1 7 HELIX 29 29 GLN B 321 LEU B 324 5 4 HELIX 30 30 ALA B 339 LEU B 341 5 3 HELIX 31 31 ASN B 342 LYS B 357 1 16 SHEET 1 A 8 MET A 70 PHE A 72 0 SHEET 2 A 8 GLN A 20 CYS A 25 1 N VAL A 23 O PHE A 72 SHEET 3 A 8 ARG A 329 ILE A 336 1 O ALA A 334 N VAL A 22 SHEET 4 A 8 ASN A 98 TYR A 104 1 N PHE A 102 O ILE A 333 SHEET 5 A 8 GLU A 254 ASP A 265 1 O ASN A 262 N ILE A 101 SHEET 6 A 8 HIS A 236 THR A 248 -1 N ILE A 243 O GLY A 259 SHEET 7 A 8 THR A 152 TYR A 164 -1 N LEU A 161 O VAL A 238 SHEET 8 A 8 GLU A 167 ASP A 170 -1 O PHE A 169 N GLU A 162 SHEET 1 B 8 MET A 70 PHE A 72 0 SHEET 2 B 8 GLN A 20 CYS A 25 1 N VAL A 23 O PHE A 72 SHEET 3 B 8 ARG A 329 ILE A 336 1 O ALA A 334 N VAL A 22 SHEET 4 B 8 ASN A 98 TYR A 104 1 N PHE A 102 O ILE A 333 SHEET 5 B 8 GLU A 254 ASP A 265 1 O ASN A 262 N ILE A 101 SHEET 6 B 8 HIS A 236 THR A 248 -1 N ILE A 243 O GLY A 259 SHEET 7 B 8 THR A 152 TYR A 164 -1 N LEU A 161 O VAL A 238 SHEET 8 B 8 ILE A 202 THR A 203 -1 O ILE A 202 N VAL A 158 SHEET 1 C 3 VAL A 41 ASP A 44 0 SHEET 2 C 3 GLU A 49 ARG A 53 -1 O GLU A 49 N ASP A 44 SHEET 3 C 3 ARG A 63 THR A 67 -1 O LYS A 64 N VAL A 52 SHEET 1 D 2 GLN A 183 ASP A 186 0 SHEET 2 D 2 VAL A 194 LYS A 197 -1 O ILE A 195 N PHE A 185 SHEET 1 E 8 MET B 70 PHE B 72 0 SHEET 2 E 8 GLN B 20 CYS B 25 1 N VAL B 23 O PHE B 72 SHEET 3 E 8 ARG B 329 ILE B 336 1 O ALA B 334 N VAL B 22 SHEET 4 E 8 CYS B 99 TYR B 104 1 N PHE B 102 O ILE B 333 SHEET 5 E 8 GLU B 254 ASP B 265 1 O ASN B 262 N CYS B 99 SHEET 6 E 8 HIS B 236 THR B 248 -1 N GLU B 247 O LEU B 255 SHEET 7 E 8 THR B 152 TYR B 164 -1 N LEU B 161 O VAL B 238 SHEET 8 E 8 GLU B 167 ASP B 170 -1 O PHE B 169 N GLU B 162 SHEET 1 F 8 MET B 70 PHE B 72 0 SHEET 2 F 8 GLN B 20 CYS B 25 1 N VAL B 23 O PHE B 72 SHEET 3 F 8 ARG B 329 ILE B 336 1 O ALA B 334 N VAL B 22 SHEET 4 F 8 CYS B 99 TYR B 104 1 N PHE B 102 O ILE B 333 SHEET 5 F 8 GLU B 254 ASP B 265 1 O ASN B 262 N CYS B 99 SHEET 6 F 8 HIS B 236 THR B 248 -1 N GLU B 247 O LEU B 255 SHEET 7 F 8 THR B 152 TYR B 164 -1 N LEU B 161 O VAL B 238 SHEET 8 F 8 ILE B 202 VAL B 204 -1 O VAL B 204 N VAL B 156 SHEET 1 G 3 VAL B 41 ASP B 44 0 SHEET 2 G 3 GLU B 49 ARG B 53 -1 O GLU B 49 N ASP B 44 SHEET 3 G 3 ARG B 63 THR B 67 -1 O LYS B 64 N VAL B 52 SHEET 1 H 2 GLN B 183 ASP B 186 0 SHEET 2 H 2 VAL B 194 LYS B 197 -1 O ILE B 195 N PHE B 185 LINK OG1 THR A 112 MG MG A 603 1555 1555 2.60 LINK O3B ADP A 601 MG MG A 603 1555 1555 2.64 LINK MG MG A 603 O HOH A 638 1555 1555 2.69 LINK OG1 THR B 112 MG MG B 602 1555 1555 2.39 LINK O3B ADP B 600 MG MG B 602 1555 1555 2.80 SITE 1 AC1 2 THR B 112 ADP B 600 SITE 1 AC2 4 THR A 112 SER A 232 ADP A 601 HOH A 638 SITE 1 AC3 16 ARG A 24 ARG A 26 PRO A 27 GLN A 106 SITE 2 AC3 16 THR A 107 GLY A 108 THR A 109 GLY A 110 SITE 3 AC3 16 LYS A 111 THR A 112 PHE A 113 GLU A 118 SITE 4 AC3 16 MG A 603 HOH A 636 HOH A 660 HOH A 664 SITE 1 AC4 15 ARG B 24 ARG B 26 PRO B 27 GLN B 106 SITE 2 AC4 15 THR B 107 GLY B 108 THR B 109 GLY B 110 SITE 3 AC4 15 LYS B 111 THR B 112 PHE B 113 GLU B 118 SITE 4 AC4 15 MG B 602 HOH B 612 HOH B 654 SITE 1 AC5 16 GLU A 116 GLY A 117 GLU A 118 ARG A 119 SITE 2 AC5 16 ALA A 133 ILE A 136 PRO A 137 LEU A 160 SITE 3 AC5 16 TYR A 211 LEU A 214 GLU A 215 GLY A 217 SITE 4 AC5 16 ALA A 218 ARG A 221 PHE A 239 HOH A 635 SITE 1 AC6 16 GLU B 116 GLY B 117 GLU B 118 ARG B 119 SITE 2 AC6 16 ALA B 133 ILE B 136 PRO B 137 LEU B 160 SITE 3 AC6 16 TYR B 211 LEU B 214 GLU B 215 GLY B 217 SITE 4 AC6 16 ALA B 218 ARG B 221 PHE B 239 HOH B 657 CRYST1 68.800 79.500 159.000 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014535 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012579 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006289 0.00000